President, Athenex Cell Therapy

Daniel Lang, MD President, Athenex Cell Therapy Dan brings to Athenex with over 25 years of medicine, healthcare investment as well as leadership and business experience. Prior to joining Athenex, Dan was the Chief Investment Officer of the RS Value franchise focused on domestic equity strategies. Dan was on the executive team of RS Investment…

Retired Chief Executive Officer – XenoBiotic Laboratories and XBL-China

Jinn Wu, PhD Retired Chief Executive Officer – XenoBiotic Laboratories and XBL-China Committees: Audit & Risk Management (member), Finance Committee (member), Scientific & Products Committee (member) Jinn Wu is the Founder and President of XenoBiotic Laboratories, Inc. (XBL) in Plainsboro, New Jersey, and XBL- China in Nanjing, China. Both are contract research organizations that provide…

Professor of Medicine and Surgery, Chief of Hepatology-Baylor College of Medicine

John M. Vierling, MD, FACP, FAASLD, AGAF Professor of Medicine and Surgery, Chief of Hepatology-Baylor College of Medicine Committees: Compensation Committee (member) John M. Vierling is a tenured Professor of Medicine and Surgery and Chief of Hepatology at the Baylor College of Medicine in Houston, Texas. He is also Director of Advanced Liver Therapies (a…

Former Chief Financial Officer – WuXi Pharmatech Inc.

Benson Tsang Former Chief Financial Officer – WuXi Pharmatech Inc. Committees: Audit & Risk Management (chairperson), Compensation Committee (member), Finance Committee (member) Benson Tsang brings over 30 years of financial and general management experience to Athenex. He previously held the role of Chief Financial Officer of WuXi Pharmatech Inc. where he was instrumental in the…

Former Chief Medical Officer – Schering-Plough

Robert J. Spiegel, M.D., FACP Former Chief Medical Officer – Schering-Plough Committees: Scientific & Products Committee (chairperson), Nominating & Corporate Governance Committee (member) Robert Spiegel has over 30 years of extensive R&D and operational experience in biopharmaceuticals, including large pharmaceutical and biotechnology companies and academic startups as well as an advisor to venture capital and…

Senior Healthcare Analyst, Maven Investment Partners

Jordan Kanfer, MPH Senior Healthcare Analyst, Maven Investment Partners Committees: Audit & Risk Management (member), Finance Committee (member) Jordan Kanfer brings over 25 years of healthcare financial experience to Athenex. He is currently a Senior Healthcare Analyst at Maven Investment Partners. Prior to his current role, Jordan was a Managing Director at Opti Capital Management,…

Chairman – Pedder Clinic
Dean of Faculty – Health Sciences, Macau University of Science and Technology

Manson Fok, MBBS, FRCS, FCSHK, FHKAM Chairman – Pedder Clinic Dean of Faculty – Health Sciences, Macau University of Science and Technology Committees: Scientific & Products Committee (member) Manson Fok is a successful medical doctor, entrepreneur and philanthropist. He is the Dean, Faculty of Health Sciences at Macau University of Science and Technology (MUST) and…

Lead Independent Director
Senior Client Partner, Private Equity/Technology Leader, North America-Korn Ferry

Stephanie Davis Lead Independent Director Senior Client Partner, Private Equity/Technology Leader, North America-Korn Ferry Committees: Compensation Committee (chairperson), Nominating & Corporate Governance Committee (member) Stephanie Davis is a Senior Client Partner at Korn Ferry, and leads the Private Equity and Technology markets in North America and is a core member of the CEO and Board…

Chief Operating Officer
President – Athenex Pharmaceutical Division

Jeffrey Yordon Chief Operating Officer President – Athenex Pharmaceutical Division Jeff has held multiple senior management positions in the pharmaceutical industry over the last 46 years. Jeff was the Founder, Chairman and CEO of Sagent Pharmaceuticals which had a market cap of $1.6 billion when he left the company in 2015. Prior to that, he…

Chief Executive Officer and Board Chairman

Johnson Y.N. Lau, MBBS, MD, FRCP Chief Executive Officer and Board Chairman Committees: Finance Committee (chairperson) Johnson is a successful pharmaceutical executive who has had extensive leadership experience in both scientific and business management. As Chairman and CEO of Ribapharm, he launched the second largest biotech IPO in U.S. history. Prior to Ribapharm, he served…